Skip to content

Prestige Consumer Healthcare

US · PBH #2733 by market cap Listed 1970
49.63 +0.03 +0.06%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Price chart

Pre-market 50.99 +2.80%
After-hours 49.63 0.00%
54.8542.9849.632026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on PBH?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is -8.9% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has risen to 9.0% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Neutral
  • Price is above its 20-day average and above its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.
Quant Rating, last 30 days D → D

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 08:27 UTC

Data coverage: 5 of 6 factors. Missing data is not a zero score.

Overall B+

The radar needs all six factors. Available grades are shown below.

Valuation A-

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 15.3x Better than 57%
Forward P/E 9.7x Better than 82%
Price / Sales 1.9x Better than 59%
P/E vs own 5-yr range 39th pctl Better than 69%
Growth C

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) -1.2% Better than 20%
Net income CAGR (3Y) 1.5% Better than 43%
Free cash flow CAGR (3Y) 3.6% Better than 43%
Profitability B+

How much profit the business keeps from each dollar of sales and capital.

Gross margin 54.7% Better than 69%
Operating margin 28.4% Better than 88%
Net margin 17.5% Better than 75%
Return on equity 10.2% Better than 53%
Return on invested capital 7.6% Better than 58%
Momentum C+

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return -3.3% Better than 66%
6-month return 3.4% Better than 62%
12-month return (ex latest month) -19.6% Better than 15%
Distance below 52-week high 30.2% Better than 42%
Financial Health B+

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 3.6x Better than 78%
Debt to assets 29.9% Better than 41%
Interest coverage 7.1x Better than 65%
Free cash flow / net income 129.5% Better than 57%
Analyst View N/A

What the Street thinks: share of Buy ratings and upside to the average target.

Not enough data to grade this factor.

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W +7.45%
1M +0.55%
3M -1.76%
6M +5.17%
YTD -19.55%
1Y -16.12%
3Y -15.67%
5Y -14.81%

Key statistics

Price & volume

Prev close
49.60
Open
49.85
Day range
49.43 - 51.23
Avg price
49.86
Volume
612.37K
Turnover
30.53M
Amplitude
3.63%
52-week range
41.77 - 71.07

Valuation

P/E
12.69
P/E (TTM)
15.32
P/B
1.21
EPS
3.91
Net profit
185.32M
Net assets
1.94B

Share structure

Market cap
2.35B
Float cap
2.32B
Shares out
47.40M
Float shares
46.72M

Dividend & listing

Dividend (TTM)
0.00
Listing date
1970-01-01
52-week range 27% of range
41.77 71.07

30.2% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-1.31M net over the window

Short interest

Shares short
4.24M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Prestige Consumer Healthcare (PBH)?

Prestige Consumer Healthcare last traded at 49.63. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Prestige Consumer Healthcare's market cap?

About 2.35B.

What is the P/E ratio of Prestige Consumer Healthcare?

The trailing twelve-month P/E is 15.32, above its own 5-year average of 4.71 — in the middle of its historical range (39.39% percentile). See the Valuation tab for the full history.

Does Prestige Consumer Healthcare pay a dividend?

Prestige Consumer Healthcare does not currently pay a regular dividend.

Is Prestige Consumer Healthcare a buy according to analysts?

The consensus of 1 analysts is a Buy rating, with an average 12-month price target of 70.00, which implies 41.0% upside from the current price. This is not investment advice.

What is Prestige Consumer Healthcare's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Prestige Consumer Healthcare a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Prestige Consumer Healthcare discussion 0 comments

Add a comment